
    
      ABI-007-PANC-003 is a Phase 3, international, multicenter, randomized, open-label, controlled
      study that will compare the efficacy of nab-paclitaxel in combination with gemcitabine to
      gemcitabine alone as adjuvant treatment for 6 cycles in patients with surgically resected
      pancreatic adenocarcinoma.
    
  